The US FDA has approved Pretomanid tablets in combination with bedaquiline and linezolid for the treatment of specific types of drug-resistant pulmonary tuberculosis.
Browsing: Clinical > Antimicrobial Resistance
Multidrug resistance to two antimalarials, used in combination as a first-line therapy, has been found using genomic surveillance to be rapidly spreading throughout Asia.
In this infographic we give you a visual snapshot of the antibiotics introduced for gonorrhea and a timeline of when resistance was first identified, in addition to setting out some of the primary resistance mechanisms.
Could board games be used as an educational tool to help teach and raise awareness around some of the major challenges in infectious diseases? In this interview we speak to Salam Abbara about the game she has helped develop, which aims to help medical students learn and understand antibiotic prescribing.
A team of researchers have demonstrated the transmission of a single bacterial strain that possessed a carbapenem-resistance gene, using whole-genome sequencing.
An in vitro study has identified potent antibiotic properties possessed by cannabidiol, discovering activity against Gram-positive bacteria such as Staphylococcus aureus and Streptococcus pneumoniae.
New research, presented at ASM Microbe (20—24 June 2019, San Francisco, CA, USA), has suggested that public campaigns have largely been ineffective at reducing antibiotic prescribing.
Researchers have shown that plant-foods, not just meats, can contribute to the transmission of antibiotic resistance to the gut microbiome.
Scientists at California State University, Fresno have identified multidrug resistance in six probiotic Bacillus strains to several antibiotics through genetic analysis.
ECCMID 2019 saw the first presentation of the results from ASPECT-NP, a randomized, multi-center Phase III trial evaluating Merck’s ZERBAXA® (ceftolozane–tazobactam) for the treatment of patients with ventilated nosocomial pneumonia. In light of this we spoke to investigators Marin Kollef and Ignacio Martin-Loeches about the rationale behind this trial, its design and the key findings.